Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's disease.
about
Are We Ready for Detecting α-Synuclein Prone to Aggregation in Patients? The Case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as Diagnostic Tools.Robust Ensemble Classification Methodology for I123-Ioflupane SPECT Images and Multiple Heterogeneous Biomarkers in the Diagnosis of Parkinson's Disease
P2860
Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Discovery, validation and opti ...... or use in Parkinson's disease.
@en
Discovery, validation and opti ...... or use in Parkinson's disease.
@nl
type
label
Discovery, validation and opti ...... or use in Parkinson's disease.
@en
Discovery, validation and opti ...... or use in Parkinson's disease.
@nl
prefLabel
Discovery, validation and opti ...... or use in Parkinson's disease.
@en
Discovery, validation and opti ...... or use in Parkinson's disease.
@nl
P2093
P2860
P1476
Discovery, validation and opti ...... for use in Parkinson's disease
@en
P2093
Anna Tasegian
Lucia Farotti
Lucilla Parnetti
P2860
P304
P356
10.1080/14737159.2017.1341312
P577
2017-06-19T00:00:00Z